PLTZ Short Volume
Daily Target 2X Short PLTR ETF (PLTZ) operates in the Financial Services sector, specifically the Asset Management - Leveraged industry, with a market capitalization near $72.7M, listed on NASDAQ, carrying a beta of 0.20 to the broader market. The Defiance Daily Target 2X Short PLTR ETF (the “Fund”) seeks daily investment results, before fees and expenses, of two times the inverse (-200%) of the daily percentage change in the share price of Palantir Technologies Inc. public since 2025-06-06.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 302.1K
- Total Volume
- 505.5K
- Short %
- 59.77%
- 30-Day Avg Short %
- 48.05%
Showing 30 days of FINRA short volume data for Daily Target 2X Short PLTR ETF.
Learn how short volume is reported and how to read the data →
Frequently asked PLTZ short volume questions
- What is the daily PLTZ short volume?
- As of Jun 1, 2026, Daily Target 2X Short PLTR ETF (PLTZ) short volume is 302.1K shares against 505.5K total reported volume, or 59.77% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is PLTZ short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does PLTZ short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.